“…For these reasons, they have been largely preferred for biosensing applications over direct approaches. Nonetheless, the current literature survey on exosome SERS analysis shows a larger number of reports based on direct approaches [ 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 ] than indirect ones [ 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 ]. This apparent anomaly may be explained by taking into considerations the intrinsic exosomal heterogeneity that currently burdens the identification of specific disease-related biomarkers for selective separation and labelling of clinically relevant exosome subpopulations [ 90 , 99 , 102 ].…”